3rd ViruSure Safety Workshop: ICHQ5A (R2) - The New Era of Biotherapeutics

This workshop promises a comprehensive exploration of biosafety testing, with a focus on the latest advancements guided by the recently revised ICH Q5A guideline—the primary reference for virus safety evaluation of biotechnology products.

Join us to explore the role of Next Generation Sequencing (NGS) in supporting and partially replacing traditional pathogen safety testing strategies. Benefit from insights shared by renowned external speakers and our in-house experts. Our distinguished speakers will share their expertise on various topics, including, new approaches in virus clearance studies, testing strategies for Advanced Therapy Medicinal Products (ATMPs), the utilization of platform technology and in-house data and the impact of Continuous Manufacturing on testing strategies.

We are very much looking forward to seeing you in Vienna!

Mon, 8.4.2024 | 08:30 - 18:00

Tech Gate Technology Tower
Donau-City-Straße 1
1220 Vienna

ViruSure website with additional information on the program, costs and how to participate